Corporate Adviser
  • Content Hubs
  • Magazine
  • Alerts
  • Events
  • Video
    • Master Trust Conference 2024 videos
  • Research & Guides
  • About
  • Contact
  • Home
  • News
  • In Depth
  • Profile
  • Pensions
    • Auto-enrolment
    • DB
    • DC
    • Defaults
    • Investment
    • Master Trusts
    • Sipps & SSAS
    • Taxation
  • Group Risk
    • Group Life
    • Group IP
    • Group CIC
    • Mental Health
    • Rehab
    • Wellbeing
  • Healthcare
    • Musculoskeletal
    • Mental Health
    • IPT
    • Wellbeing
    • Trusts
    • Cash Plans
  • Wellbeing
    • Mental Health
    • Health & Wellbeing
    • Financial resilience
  • ESG
No Result
View All Result
Corporate Adviser
No Result
View All Result

Maxis GBN to use virtual reality programme to help smokers quit

by Emma Simon
May 17, 2022
Share on FacebookShare on TwitterShare on LinkedInShare on Pinterest

Maxis GBN has partnered with MindCo Health to offer clients new virtual programmes designed to stop smoking and ease stress.

Californian-based MindCo Heath is a digital health company specialising in VR programmes centred on mental health. 

This partnership follows a number of other similar initiatives, which has seen Maxis GBN join forces with a number of technology companies in the ‘wellness’ sector.

Maxis GBN will offer multinationals ‘MindCotine’ which helps people tackle smoking addiction through a combination of VR experiences, cognitive behavioural therapies, mindfulness exercises, and live coaching.

Clients will also have access to the company’s MindCoRelief product, a VR mindful exposure therapy programme that aims to help people deal with anxiety and stress.

Multinationals will be able to offer employees access to both support programmes with four methods of engagement:

  • a physical kit, including a VR headset
  • virtual training, including VR exposure scenarios
  • a mobile app which can track progress
  • a human coach, offering weekly coaching sessions and 24/7 support through the app’s chat function

Maxis GBN says MindCotine is the first clinically validated VR smoking cessation programme in the world. According to a study conducted with researchers from Johns Hopkins University, the MindCotine programme yielded 33 per cent smoking cessation efficacy at 90 days, compared to 16 per cent for those using a nicotine patch and 12 per cent for those using cognitive behavioural therapy (CBT) counselling alone.

Maxis GBN head of health and wellness Dr. Leena Johns adds: “Smoking remains a major challenge for society, with significant health and financial impacts. The MindCotine product is a new and proven way to help employees with this challenge and in turn boost their health. 

“We’re delighted to be adding MindCo to our roster of partners and expect strong demand from employers looking to help their people overcome their smoking addiction.

“And as mental health becomes an even more important subject in the workplace, we are pleased that we can offer MindCoRelief to help employers ease their people’s stress and anxiety.”

Corporate Adviser Special Report

REQUEST YOUR COPY

Most Popular

  • Death-in-service benefits excluded from IHT grab

  • Aviva launches ‘flex first, fix later’ retirement option for master trust savers

  • Baroness Drake leads revived Pensions Commission re-examining AE levels and SPA

  • Laura Mason: This is the moment for targeted pension support

  • Industry welcomes revived Pension Commission

  • Stancombe to lead retirement platform business

Corporate Adviser

© 2017-2024 Definite Article Media Limited. Design by 71 Media Limited.

  • About
  • Advertise
  • Privacy policy
  • T&Cs
  • Contact

Follow Us

X
No Result
View All Result
  • Home
  • News
  • In Depth
  • Profile
  • Pensions
    • Auto-enrolment
    • DB
    • DC
    • Defaults
    • Investment
    • Master Trusts
    • Sipps & SSAS
    • Taxation
  • Group Risk
    • Group Life
    • Group IP
    • Group CIC
    • Mental Health
    • Rehab
    • Wellbeing
  • Healthcare
    • Musculoskeletal
    • Mental Health
    • IPT
    • Wellbeing
    • Trusts
    • Cash Plans
  • Wellbeing
    • Mental Health
    • Health & Wellbeing
    • Financial resilience
  • ESG

No Result
View All Result
  • Home
  • News
  • In Depth
  • Profile
  • Pensions
    • Auto-enrolment
    • DB
    • DC
    • Defaults
    • Investment
    • Master Trusts
    • Sipps & SSAS
    • Taxation
  • Group Risk
    • Group Life
    • Group IP
    • Group CIC
    • Mental Health
    • Rehab
    • Wellbeing
  • Healthcare
    • Musculoskeletal
    • Mental Health
    • IPT
    • Wellbeing
    • Trusts
    • Cash Plans
  • Wellbeing
    • Mental Health
    • Health & Wellbeing
    • Financial resilience
  • ESG

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.